Funded Tech Companies

Rgenta Therapeutics

Rgenta Therapeutics is a leading biopharmaceutical tech company, based in Cambridge. Venture investment and financing was provided by AstraZeneca, Korea Investment Partners and Delos Capital.

Company Overview

Contact Information

Company Background Information

Overview

Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders. Our proprietary platform mines the massive genomics data to identify targetable RNA processing events and design small-molecule glues to modulate the interactions among the spliceosome, regulatory proteins, and RNAs.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

11/29/2022

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Simon Xi

        

Chief Scientific Officer

Travis Wager

        

Company Investors

• AstraZeneca
• Korea Investment Partners
• Delos Capital
• Boehringer Ingelheim Venture Fund (Martin Heidecker)
• Legend Star
• Matrix Partners
• Kaitai Capital

Browse more funded tech companies:

RGB Networks | RGFREE

Share this article

About Our VC Deals Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary